Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07243574 · ClinicalTrials.gov registry record · NA
Night Owl Sleep Study: The Effect of Sleep on Fecal Microbiota
A NA study of Sleep, sponsored by Danis.
- Recruiting
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 3
- Study locations
NCT07243574: Recruiting NA study of Sleep, sponsored by Danis.
NCT07243574 is a NA study of Sleep that is actively recruiting participants, run by Danis. The registered enrollment target is 174 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07243574, a NA study of Sleep, is actively recruiting participants, sponsored by Danis.
- RECRUITING
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to assess differences in the fecal microbiota and metabolome associated with insufficient and sufficient sleep, and to evaluate the response and recovery of the microbiota to changes in participant sleep profiles. Researchers will compare the effect of sleep intervention on both insufficient and sufficient sleepers to identify differences in fecal microbiota structure and function between cohorts during habitual sleep and during the sleep alteration intervention period.. Participants will be assigned to one of two cohorts based on their current sleep habits. Cohort 1 are participants who have insufficient sleep at baseline; this cohort will be assigned to spend 1.5 hours more in bed per night. Cohort 2 are participants who have sufficient sleep at baseline; this cohort will be assigned to spend 1.5 hours less in bed per night. The sleep intervention lasts for 14 days.
Primary Outcome
Measure changes in microbial abundance and diversity from baseline to the end of the study in those individuals who have sufficient sleep compared to those with insufficient sleep. This is comparing the sufficient sleep group to the insufficient sleep group across all study periods.
Conditions Studied
Interventions
- BEHAVIORAL Increase sleep by 90 minutes
- BEHAVIORAL Decrease sleep by 90 minutes
Study Locations (3)
Florida
- Global Life Research Network - Miami
Massachusetts
- Lindus Health - Boston
New York
- AccuMed - Garden City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT07243574 shows while recruiting
NCT07243574 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Increase sleep by 90 minutes is the first listed.
NCT07243574 reports a single indexed study location in Florida, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT07243574 about?
NCT07243574 is a clinical study titled "Night Owl Sleep Study: The Effect of Sleep on Fecal Microbiota". The goal of this clinical trial is to assess differences in the fecal microbiota and metabolome associated with insufficient and sufficient sleep, and to evaluate the response and recovery of the microbiota to changes in participant sleep profiles. Researchers will compare the effect of sleep inter...
What is the current status of trial NCT07243574?
This trial is currently recruiting. It is a NA study. The enrollment target is 174 participants. The study started on 2025-09-17. Estimated completion is 2026-07.
What conditions does trial NCT07243574 study?
This clinical trial studies the following conditions: Sleep.
What interventions are being tested in trial NCT07243574?
The interventions under investigation include: Increase sleep by 90 minutes (BEHAVIORAL), Decrease sleep by 90 minutes (BEHAVIORAL).
Who is sponsoring clinical trial NCT07243574?
This trial is sponsored by Danis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07243574 being conducted?
This trial has 3 study locations across Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07243574's enrollment target sits among peer trials
174 38th of 151 higher than 114 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI